Back to 2024 Agenda
What are the other components of the NASEM Digital Twin?
Charge to Speakers:
Consider the expert topics for each presentation. How can BDT developers incorporate these tools, resources and mindset?
What are some major components:
- Fit-for-Purpose BDT
- Verification, Validation, and Uncertainty Quantification (VVUQ)
- Physical Assets/Data Collection/Sensors
- Mathematical and Statistical Foundations for BDT
- Virtual to Physical Control Algorithms/Expert in the Loop
- Ethical, Security Issues
- Team Science, Governance
Part 1: Technical Components
Each speaker will present a 10-minute talk, followed by 5 minutes for questions
Reinhard Laubenbacher: Embedded mathematical, statistical, and computational algorithms for VVUQ, virtual assets and data/knowledge systems
Julian Goldman: Real-time measurements for closed loop control to address systems of systems interoperability for regulated BDTs
Part 2: Social Components
Each speaker will present a 10-minute talk, followed by 5 minutes for questions
Michelle Bennett: Team Science, governance to consider sustainability
Barbara Evans: Embedding a culture of ethical inquiry, privacy, and consent for trustworthy BDT
Speaker Bios:
Moderator Bio:
Materials:
Presentations:
Comment
Who owns the DT? or, at least have control over what happens to the DT after the purpose is achieved? Should the patient have a say in whether it is automatically archived or disposed off?
Are current laws on regulating patient records and HIPAA sufficient to deal with this?
Manufactures are very protective and conservative. They are interested in only having their devices work together in their own ecosystem of devices.
How do you think is the best way to incentivize and/or enforce interoperability for between manufacturers?
As digital twin technology advances, particularly in predictive modeling for mental health and Substance Use Disorder (SUD), how can we rigorously safeguard patient autonomy, privacy, and prevent algorithmic bias, especially considering the potential implications for individuals facing stigma or legal consequences?
Wonderful panel discussion. Question for Dr. Bennett. I thought it was interesting that teams are more likely to disintegrate with more experts. Does the way that we train our experts have to do with the teams disintegrating or is it more a "curse of knowledge"?
Great lectures, especially Dr. Julian Goldman, for an insightful presentation on the SaAMS Collaborative Community and ACLIVA. The emphasis on shared safety standards and pre-competitive collaboration is a brilliant approach to tackling key challenges in medical device innovation. Excited to see how this initiative will shape the future of anesthesia and patient care.